Enjoy complimentary customisation on priority with our Enterprise License!
The premenstrual syndrome (PMS) market size is forecast to increase by USD 276.72 million at a CAGR of 3.69% between 2023 and 2028. The Premenstrual Syndrome (PMS) market is experiencing significant growth due to increasing awareness and reporting about this condition. Women are increasingly seeking effective treatment options to manage the physical symptoms and mood swings associated with their menstrual cycle. Hormonal contraceptives and antidepressants remain popular choices, but there are also growing demands for alternative treatments such as herbal medicines, vitamin supplements, and micronutrients like calcium, magnesium, vitamin B6, and potassium. Pharmacies and e-commerce platforms are making these treatments more accessible, with some offering home delivery and telemedicine consultations. However, supply shocks and adverse events associated with certain medications, such as diuretics and pain relievers, can pose challenges.
Furthermore, the prevalence of PMS is high, with an estimated 75% of menstruating women experiencing some symptoms. Sedentary lifestyles and the luteal phase of the menstrual cycle can exacerbate symptoms, leading to increased demand for treatment. Treatment options range from lifestyle modifications to pharmaceutical interventions. Luteal phase therapy and pH level balancing are gaining popularity, but these treatments can have negative side effects depending on the drug type. Organic chasteberry and other herbal medicines are also being explored as potential alternatives, but their efficacy and safety require further research. Overall, the PMS market is expected to continue growing as more women seek effective and accessible treatment options for their menstrual cycle symptoms.
Premenstrual Syndrome (PMS) is a collection of physical and emotional symptoms that women experience during the menstrual cycle. The symptoms include mood swings, bloating, fatigue, irritability, cramps, acne, sore breasts, and depression or anxiety. According to public knowledge, PMS affects a significant portion of women worldwide, leading to a high demand for effective treatment. The market for PMS medications includes various types of drugs such as antidepressants and hormonal contraceptives. These medications help alleviate the symptoms by regulating hormonal imbalances. However, supply shocks and accessibility issues can impact the market, particularly in rural areas and developing countries. Healthcare companies are exploring new avenues to cater to the target market, such as mobile apps, telemedicine, and e-commerce platforms.
Moreover, these channels offer convenience and accessibility, enabling women to purchase medications and consult with healthcare professionals from the comfort of their homes. Moreover, alternative treatments like herbal remedies, vitamin supplements, and diuretics are gaining popularity due to their fewer adverse events compared to traditional medications. In conclusion, the PMS drug market is expected to grow significantly due to the increasing awareness and demand for effective treatments, along with the advancements in technology and accessibility of medications.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The analgesics segment is estimated to witness significant growth during the forecast period. Premenstrual Syndrome (PMS) is a common health condition affecting a significant portion of women during their menstrual cycle. Symptoms such as acne, sore breasts, bloating, exhaustion, irritability, and mood swings can impact daily life and productivity. Antidepressants and hormonal contraceptives are among the common treatments for PMS, although they may come with adverse events and supply shocks. Pharmacies and e-commerce platforms offer various treatment options, including analgesics, diuretics, vitamin supplements, herbal medicines, and micronutrients like calcium, magnesium, vitamin B6, and potassium. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, aspirin, and naproxen, are popular choices for relieving pain and reducing inflammation during menstruation.
Acetaminophen (Paracetamol) is another analgesic that is effective for pain relief but does not have anti-inflammatory properties. Mobile apps and telemedicine services offer increased accessibility to consultations with healthcare professionals, enabling women to discuss their symptoms and treatment options without leaving their homes. However, it is essential to consider potential side effects and negative interactions with other medications before starting any new treatment. Organic chasteberry is a popular herbal medicine for PMS relief, although its effectiveness is still under debate. According to recent studies, the prevalence of PMS is high, with sedentary lifestyles and stress contributing to its exacerbation.
Moreover, luteal phase therapy, which involves administering hormones during the second half of the menstrual cycle, is a newer treatment option gaining popularity. Pain relievers, including NSAIDs and acetaminophen, remain the most commonly used treatments for PMS symptoms. Understanding the different drug types, their mechanisms, and potential side effects is crucial for women seeking effective and safe relief from PMS symptoms.
Get a glance at the market share of various segments Request Free Sample
The analgesics segment accounted for USD 680.61 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
Premenstrual Syndrome (PMS) is a common health condition affecting women during their menstrual cycle. Symptoms such as acne, sore breasts, bloating, exhaustion, irritability, and mood swings can significantly impact women's daily lives. Various treatment options are available to alleviate these symptoms, including antidepressants, hormonal contraceptives, and alternative therapies like herbal medicines and vitamin supplements. The global market for PMS treatments has been expanding due to factors such as increasing public knowledge, accessibility of medications through channels like e-commerce and telemedicine, and the prevalence of sedentary lifestyles. In 2023, North America dominated this market, driven by a strong culture of health awareness, extensive medical capabilities, and a large patient population.
Furthermore, the US, in particular, holds a significant share due to its strong healthcare system and high healthcare spending. Traditional treatments for PMS include diuretics, calcium, magnesium, vitamin B6, and potassium. However, these treatments may come with side effects, and some women prefer alternative therapies like luteal phase therapy or organic chasteberry. Pharmacies and online platforms offer a wide range of PMS treatments, making them more accessible to women. However, it's crucial to consult a doctor before starting any new medication to understand potential adverse events. Technological advancements, such as mobile apps and wearable devices, help women monitor their menstrual cycles and symptoms, enabling them to manage their PMS more effectively.
Furthermore, despite these advancements, negative side effects and the varying effectiveness of different treatments can limit the growth of the PMS market. Understanding the drug type and potential side effects is essential for women to make informed decisions about their treatment options. Pain relievers are a common choice for managing physical symptoms, but they may not address the underlying hormonal imbalances. In conclusion, the global PMS market is expected to continue growing due to increasing awareness, technological advancements, and the availability of various treatment options. However, understanding the unique needs and preferences of the target market, as well as the potential side effects and effectiveness of different treatments, is crucial for market success.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing awareness and reporting about PMS is the key driver of the market. The global market for Premenstrual Syndrome (PMS) treatments is experiencing significant growth due to increased public knowledge and awareness about this condition. Symptoms such as acne, sore breasts, mood swings, bloating, exhaustion, and irritability are increasingly being recognized and reported to healthcare providers. Hormonal contraceptives and antidepressants are common treatments for PMS, but supply shocks and adverse events can limit their accessibility. In response, alternative treatments like diuretics, vitamin supplements, herbal medicines, and micronutrients such as calcium, magnesium, vitamin B6, and potassium have gained popularity. Pharmacies, mobile apps, telemedicine, and e-commerce platforms have made these treatments more accessible. Luteal phase therapy and pH level balancing are emerging treatment options.
Moreover, while these treatments offer relief from physical symptoms, it is essential to consider potential side effects and consult a healthcare professional before use. The prevalence of PMS is high, particularly among women with sedentary lifestyles. Organic chasteberry and other natural remedies are also gaining popularity as treatment options. The growing awareness and acceptance of PMS as a valid health concern will continue to drive demand for effective and accessible treatments during the forecast period.
strong adoption of telemedicine is the upcoming trend in the market. Premenstrual Syndrome (PMS) is a common health condition that affects women during their menstrual cycle, causing a range of physical and emotional symptoms. These symptoms include acne, sore breasts, bloating, exhaustion, irritability, and mood swings. Antidepressants and hormonal contraceptives are commonly used to manage PMS symptoms, but supply shocks and accessibility issues can limit their availability in pharmacies. To address these challenges, innovative solutions such as mobile apps, e-commerce platforms, and telemedicine have emerged. Telemedicine, in particular, plays a significant role in boosting the accessibility and reach of PMS treatment. It has removed geographical barriers, allowing individuals in remote or underserved areas to access healthcare professionals specializing in PMS treatment.
Furthermore, this accessibility has led to increased consultations and advice-seeking for managing PMS symptoms. Virtual consultations via telemedicine platforms offer convenience, allowing individuals to seek advice and treatment without the need for in-person visits. This convenience is particularly beneficial for individuals not only experiencing PMS symptoms but also facing time constraints or mobility issues. Telemedicine offers a level of privacy and comfort for individuals discussing sensitive topics such as menstrual health and PMS symptoms. Additional treatment options for PMS include diuretics, vitamin supplements, herbal medicines, and micronutrients such as calcium, magnesium, vitamin B6, and potassium. While these alternatives may have fewer side effects than prescription medications, they should be used with caution and under the guidance of a healthcare professional. The prevalence of PMS is high, with sedentary lifestyles and stress contributing to its incidence. Luteal phase therapy and pH level balancing are also effective treatment options for managing PMS symptoms. However, it is essential to be aware of the negative side effects and potential adverse events associated with various drug types, including pain relievers. Consulting a healthcare professional before starting any new treatment is crucial to ensure safety and effectiveness. In conclusion, the PMS drug demand continues to grow, driven by the increasing awareness and understanding of this condition. The accessibility of medications and treatment options, including telemedicine, mobile apps, and e-commerce platforms, has expanded, making it easier for women to manage their symptoms and improve their overall well-being.
Diagnostic complexity with PMS is a key challenge affecting the market growth. Premenstrual Syndrome (PMS) is a common condition among women, characterized by a range of physical, emotional, and behavioral symptoms that can significantly impact daily life. These symptoms, which may include mood swings, fatigue, breast tenderness, acne, bloating, and irritability, can vary in type, severity, and duration among individuals. While there are no definitive laboratory tests or specific diagnostic criteria for PMS, diagnosis typically involves assessing a woman's reported symptoms and their timing in relation to her menstrual cycle. The market for PMS treatments is diverse and includes various options such as antidepressants, hormonal contraceptives, and alternative therapies like herbal medicines, vitamin supplements, and micronutrients.
Furthermore, commonly used micronutrients for PMS include calcium, magnesium, vitamin B6, and potassium. However, the availability and accessibility of these medications can be affected by supply shocks and other factors, making it essential for women to have multiple options for obtaining them. Pharmacies, mobile apps, telemedicine, and e-commerce platforms have emerged as convenient and accessible channels for women to access PMS treatments. These channels offer the added benefits of privacy, convenience, and reduced wait times for consultations with healthcare professionals. However, it is crucial for women to be aware of the potential side effects and adverse events associated with various PMS treatments, including diuretics, pain relievers, and hormonal contraceptives. The prevalence of PMS is high, with estimates suggesting that up to 95% of menstruating women experience some symptoms during their menstrual cycle. Sedentary lifestyles and other lifestyle factors can exacerbate PMS symptoms, making luteal phase therapy and other targeted treatments increasingly popular. Ultimately, the choice of PMS treatment depends on the individual's specific symptoms, severity, and personal preferences. It is essential to consult a healthcare professional for a proper diagnosis and to discuss the potential benefits and risks of various treatment options. Organic chasteberry and other herbal medicines have also gained popularity as natural alternatives for managing PMS symptoms. However, it is essential to be aware of the potential negative side effects and drug interactions associated with these treatments.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
AbbVie Inc. - The company offers pre menstrual syndrome drug such as ORIAHNN for managing heavy menstrual bleeding associated with fibroids in premenopausal women.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Premenstrual Syndrome (PMS) is a common disorder characterized by physical and emotional symptoms that occur during the menstrual cycle. The prevalence of PMS varies across countries, with an estimated 75% of women experiencing some form of premenstrual symptoms. The market for PMS treatments is witnessing significant growth due to the increasing awareness of the disorder and the availability of various treatment options. The target market for PMS drugs includes women of reproductive age. The demand for medications to manage PMS symptoms is driven by the adverse events associated with these symptoms, such as mood swings, bloating, fatigue, irritability, cramps, depression, and anxiety.
Furthermore, the market for PMS treatments includes various medication types, such as antidepressants, hormonal contraceptives, diuretics, vitamin supplements, herbal medicines, and micronutrients like calcium, magnesium, vitamin B6, and potassium. The use of these medications can help alleviate symptoms such as bloating, mood swings, and pain. The accessibility of medications for PMS treatment has been improved through various channels, including pharmacies, e-commerce platforms, telemedicine, and mobile apps. The preference for these delivery systems is driven by their convenience and safety. The market for PMS treatments is expected to grow due to the development of new drugs, such as relugolix, estradiol, and norethindrone acetate, which offer pain relief and fever reduction.
Moreover, the growth of the market is also driven by the increasing prevalence of PMS and the availability of alternative treatment options, such as luteal phase therapy and lifestyle changes. Despite the availability of various treatment options, the use of these medications comes with potential side effects, and some women may prefer herbal remedies or supplements. The market for herbal remedies and supplements includes organic chasteberry, which has been shown to alleviate PMS symptoms. The growth of the PMS market is influenced by factors such as sedentary lifestyles, stress management, and diet and exercise changes. The market for PMS treatments is expected to continue growing due to the increasing awareness of the disorder and the availability of various treatment options.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
158 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.69% |
|
Market growth 2024-2028 |
USD 276.72 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
3.22 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 39% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
AbbVie Inc., Aspen Pharmacare Holdings Ltd, Bayer AG, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, Herbalife International of America Inc., Hikma Pharmaceuticals Plc, Johnson and Johnson, Lupin Ltd., Merck KGaA, Novartis AG, Octavius Pharma Pvt. Ltd., Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Recordati S.p.A, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Drug Class
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.